Health Care
(E70)
IRS Verified
DX Registered
990 on File
VAX 2 STOP CANCER
Financial strength (30%)
76/100
Reliability (20%)
45/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
To prevent cancer by expanding the use of the human papillomavirus (HPV) vaccine through education, public awareness, and advocacy to reduce the burden of HPV-associated cancers.
Financial Overview — FY 2024
$152K
Total Revenue
$178K
Total Expenses
$151K
Net Assets
4
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
90.6%
Fundraising Efficiency
0.0%
Operating Reserve
10.15x
Liability-to-Asset
0.0%
Revenue Diversification
103.1%
Executive Compensation
$63K
Compared with Peers
FY 2024
Compared with 4,558 similar organizations
(United States, Health Care, $100K–$1M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
90.6% | 84.8% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
9.5% | 10.9% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
0.0% | 12.6% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
10.2 mo | 13.1 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 1.3% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
103.1% | 93.7% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
-35.8% | 7.3% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
1.0% | 7.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-17.4% | 3.7% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $152K | $178K | $151K | 90.6% | 4 |
| 2023 | $237K | $177K | $177K | 90.2% | 4 |
| 2022 | $169K | $162K | $117K | 87.0% | — |
| 2021 | $326K | $118K | N/A | — | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.